If you look at the funding for R and D in the health field, not just pharmaceutical health field in general and you take into account tax credits, basically business expenditures in R and D represent only 19% of the total spending.
I'd really like to finish with this last slide. It doesn't appear any more, but it said that somebody has to do something, and it's incredibly pathetic that it has to be us.